Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis.

PloS one - 1 Jan 2017

Frouws Martine A, Reimers Marlies S, Swets Marloes, Bastiaannet Esther, Prinse Bianca, van Eijk Ronald, Lemmens Valery E P P, van Herk-Sukel Myrthe P P, van Wezel Tom, Kuppen Peter J K, Morreau Hans, van de Velde Cornelis J H, Liefers Gerrit-Jan

Abstract excerpt

BACKGROUND: Use of aspirin after diagnosis of colon cancer has been associated with improved survival. Identification of cancer subtypes that respond to aspirin treatment may help develop personalized treatment regimens. The aim of this study was to investigate the influence of BRAF and KRAS mutation status on the association between aspirin use and overall survival after colon cancer diagnosis. METHODS: A random...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aspirin
Share to Colon

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colonic Neoplasms

Share to Gene Expression

Share to Proto-Oncogene Proteins B-raf

Share to Proto-Oncogene Proteins p21(ras)

Share to Registries

Share to Survival Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 28125730
DOI: 10.1371/journal.pone.0170775
PMCID: PMC5268402

Genes

BRAF
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis.PMID 28125730Read ↗

Aspirin use and risk of colorectal cancer according to BRAF mutation status.Semantic proximity Read ↗

Expression of HLA class I antigen, aspirin use, and survival after a diagnosis of colon cancer.Semantic proximity Read ↗

Examining the impact of regular aspirin use and PIK3CA mutations on survival in stage 2 colon cancer.Semantic proximity Read ↗

Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.Semantic proximity Read ↗

PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies.Semantic proximity Read ↗

Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis.Semantic proximity Read ↗

Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort StudySemantic proximity Read ↗

Statin Use After Diagnosis of Colon Cancer and Patient Survival.Semantic proximity Read ↗

Aspirin and Cancer: An Updated MinireviewSemantic proximity Read ↗

Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation.Semantic proximity Read ↗

The Association Between Colorectal Cancer and Pharmaceuticals with Emphasis on Low-Dose Aspirin and AnticoagulantsSemantic proximity Read ↗

The Protective Effects of Aspirin Use from Adverse In Hospital Outcomes and Metastatic Disease in Colorectal Cancer: An Evaluation of the National Inpatient SampleSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.